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Abstract 19 
Purpose of review: There is an increasing body of evidence from epidemiology and 20 
laboratory investigations on periodontal disease being a risk factor for dementia. In particular, 21 
Porphyromonas gingivalis infections in animal models suggest causal associations with 22 
Alzheimer’s disease (AD). This review focusses on how P. gingivalis infections promote the 23 
incidence of functional loss in AD.  24 
Latest findings: The risk of the sporadic form of AD doubles when periodontitis persists for 25 
ten or more years. AD differs from other forms of dementia in that the clinical signs together 26 
with the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles must be present at 27 
autopsy. P. gingivalis oral infections in mice have demonstrated all of the characteristic 28 
pathological and clinical features of AD following infection upon their entry tof the brain. 29 
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Summary: Multiple factors (inflammation, Aβ oligomers, and bacterial factors) are likely to 30 
disrupt neuronal communication channels (synapses) as a plausible explanation for the 31 
functional loss.  32 
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Introduction 42 
Longstanding periodontitis, formerly known as “chronic” periodontitis has an adverse effect 43 
on a number of complex human diseases associated with longstanding inflammation [1-3]. 44 
Recent research has linked poor oral hygiene to other neurological conditions that manifest 45 
with dementia. Currently they include the sporadic form of Alzheimer’s disease (AD), and the 46 
Lewy body Parkinson’s disease (dementia) [4-6]. Amyloid-beta (Aβ) plaques are central to all 47 
forms of dementia, but are more important to AD pathology. A significant body of literature 48 
considers the Aβ plaques of AD and the α-synuclein of Lewy bodies to be antimicrobial 49 
peptides that combat infections of the brain [7-10]. This concept may provide vital clues to 50 
the occurrence of these neuropathological lesions.  51 
 52 
Porphyromonas gingivalis  53 
Porphyromonas gingivalis is found in the oral cavity (saliva) of all humans where it may or 54 
may not cause oral pathology, but is able to tolerate low concentrations of oxygen 55 
(microaearophilic). In addition, recent research has implicated P. gingivalis as the keystone 56 
pathogen of periodontitis, which is an inflammatory disease constituting complex dysbiotic 57 
microbial community residing below the gumline, within “pockets”. P. gingivalis appears to 58 
translocate from the saliva to the subgingival location using neutrophils as “Trojan horses” in 59 
some individuals because clinical observations suggest that not everyone progresses to 60 
manifesting periodontal disease.  61 
The mouth harbours a microbiome, which essentially is a reservoir of health 62 
promoting microbes until their balance changes to more pathogenic forms. The fact that P. 63 
gingivalis can act as a commensal,and provides us with an opportunity to discuss the role of 64 
its source of Porphyromonas gingivalis its primary oral source to its access of the brain in 65 
relation to cognitive dysfunction. This is not only because AD is a prime example of a 66 
dementing neurological disease but also forthat has a plausible the established  association 67 
withof  P. gingivalis with both the AD brain [11, 12]. and periodontitis as a keystone 68 
bacterium [12]. In addition, This is strengthened by the development of models for 69 
periodontal infection and AD in mice P. gingivalis infection to the brain directly from its 70 
primary oral niche [13] where it has been demonstrated to can reproduce the cardinal 71 
hallmark pathology inclusive of Aβ plaques, phosphotau [14], and cognitive function in 72 
experimental mice [15-17]. 73 
 74 
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Alzheimer’s disease 75 
AD is end of life stage and the most common example of dementia. The cardinal clinical signs 76 
are cognitive decline with deterioration in memory. The hHippocampus is the region of the 77 
brain where memory is processed and the functional loss has been associated with the death of 78 
neurons in specific regions of the brain related to memory. AD has a long preclinical phase 79 
(20 years) with the duration of suffering lasting on average for 8-10 years and longer [18]. At 80 
the preclinical stage of the illness, the individual may not seek medical help. Usually a family 81 
member or the caregiverr of the person with declining cognition and memory may voice their 82 
concern to a health care professional. This may be their general medical practitioner (GP) or a 83 
health care professional (district nurse). The first stage in exploring this health complaint is 84 
for the caregiverr to take the person (with suspected dementia signs) to his/her GP. The GP 85 
will then refer the person on to a memory service to establish a more formal clinical 86 
diagnosis, and initiate treatment and support. The final diagnosis of AD rests with both the 87 
clinical history together with the demonstration of the neuropathological occurrence of Aβ 88 
plaques and hyperphosphorylated tau protein binding to neurofibrillary tangles in a 89 
characteristic pattern and distribution in the specific regions of the brain. AD neuropathology 90 
can co-exist with other neurological and/or vascular pathologies because it is not an isolated 91 
disease.  92 
 93 
Plausible cause of Alzheimer’s disease and Lewy-body dementia  94 
The cause of the sporadic forms of the neurological diseases under discussion (AD and 95 
Parkinson’s disease with Lewy bodies) remains unclear. However, amongst others, the risk 96 
factors include ageing and inheritance of the apolipoprotein E gene allele 4 (APOE є4) [19, 97 
20]. The APOE є4 susceptibility gene links with environmental risk factors that include the 98 
host’s dysbiotic oral microbiome [21]. P. gingivalis infections of the brain in laboratory mice 99 
induced with periodontitis demonstrate excessive oxidative stress and inflammation [13-15, 100 
22].  101 
Lewy bodies are intra-neuronal cytoplasmic inclusions composed of synuclein and 102 
other proteins lying within the pigmented neurons of the substantia nigra, limbic and the 103 
cerebral cortex regions of the brain. The clinical symptoms of Parkinson’s disease in its purest 104 
form are tremor, immobility and rigidity of muscles. However, cognitive deficit occurs when 105 
Parkinson’s disease co-exists with dementia (Lewy body Parkinsonian dementia), see 106 
comment above related to mixed pathologies. Epidemiological investigations [4, 5] in a 107 
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Taiwanese population have linked this to periodontal disease. As mentioned earlier, the Aβ 108 
protein of AD plaques and the α-synuclein within Lewy bodies are a form of broad-spectrum 109 
antimicrobial peptides, released following infection, including that caused by the periodontal 110 
pathogen P. gingivalis [7-10, 14]. If Aβ and α-synuclein represent the host’s response to a 111 
previous infection, it follows that these neurodegenerative diseases have causative 112 
associations with microbes during their development. This has given rise to the antimicrobial 113 
protection hypothesis [23] linking infection as a plausible trigger for the sporadic form of AD. 114 
If this theory becomes widely accepted, then explaining the existing oxidative stress, the 115 
activated complement, the longstanding inflammation and the defects in the blood-brain 116 
barrier (BBB) would be easy in the context of P. gingivalis infection [13, 22, 24]. All of the 117 
above-mentioned signaling cascades and others (not included here), would enhance the role of 118 
Aβ as an antimicrobial peptide in killing the elusive invader(s) and/or the little understood 119 
brain’s own microbiome converting to a pathobiome. In addition, the elderly are unlikely to 120 
be immuno-privileged because the BBB defects in the 70+ year’s age group are associated 121 
with more rapid cognitive decline [25] and could have implications for pathogen entry.  122 
 123 
Plausible cause of cognitive deficit 124 
What actually causes the cognitive deficit during dementia onset is unclear, because the 125 
individual examples of dementia such as AD are seldom pure. However, the amyloid cascade 126 
hypothesis originally focused on Aβ deposits as a possible cause [26]. Subsequent 127 
immunological therapy to remove Aβ plaques from the brains of AD patients disproved the 128 
notion that insoluble Aβ deposits contribute to cognitive dysfunction [27]. Prior to the 129 
amyloid hypothesis, the synaptic loss hypothesis of Terry et al. [28] and Masliah et al. [29] 130 
originated from the fact that specific neuronal loss may be due to synaptic loss. The revised 131 
version of the amyloid cascade hypothesis has incorporated soluble oligomeric Aβ in the 132 
synaptotoxicity and cognitive impairment theory [30]. It is possible that there is close 133 
interplay between the mechanisms underlying these three hypotheses. After all, it is highly 134 
plausible that microbial debris, inflammatory mediators, oligomeric Aβ, smaller tau peptides 135 
released by gingipains, and pathogen activated inflammasomes [31], can all act to disrupt 136 
synapses and result in cognitive deficit.   137 
 138 
Relationship between periodontitis and AD 139 
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The idea of dementia being a risk factor for periodontitis is undisputable, but then one would 140 
expect all demented individuals to have periodontitis by the time of death. Literature suggests 141 
the formerly known “chronic” periodontitis has a clearer relationship with a subgroup of AD 142 
cases [32-36]. Significant progress will only be made to find the actual direction of this 143 
relationship, once we better understand the parameters that should be included and/or 144 
excluded from the investigation in case control and/or cohort studies. For example, we now 145 
understand that periodontitis only becomes a risk factor for AD development some 10 years 146 
after it is diagnosed [37, 38]. This would imply that studies conducted in less than 10-year 147 
cohort analysis would provide inconclusive results [39]. One suggested risk of developing AD 148 
is having fewer remaining teeth (loss of up to 9 teeth) in early to mid-life due to periodontitis 149 
[30, 40], resulting from longstanding poor oral hygiene. For a more comprehensive discussion 150 
on the direction of the relationship between oral health and risk of developing AD, see Daly et 151 
al. [41]. There is agreement that periodontitis doubles the risk for developing late onset AD 152 
with an odds ratio of 2.2 (95% CI 1.1, 4.5) 10 years after its initial diagnosis [37, 38]. An 153 
interventional study on the periodontal treatment in AD patients [42] indicated a plausible 154 
causal relationship in demented individuals. It is suggested that patients with early stage 155 
dementia (at the time ofpoint when they visiting the memory clinic for initial diagnosis) show 156 
worsening oral hygiene [43], implying that dementia may be the risk factor for periodontal 157 
disease in this group of patients. It is also suggested that if dental intervention is provided at 158 
the early stage of dementia onset, it would delay the speed of cognitive deterioration. Early 159 
intervention is important and memory clinics should consider taking it on at the time the 160 
initial diagnosis [43]. However, to confirm the direction of the relationship, more studies with 161 
larger cohorts are needed in the “at risk” subpopulation of individuals whose periodontitis co-162 
exists with AD cases. In addition, future interventional studies should include participants 163 
who suffer from periodontitis approaching the risk age for dementia (pre 65-year age) for 164 
maximal impact on delaying the onset of AD.  165 
 166 
Relationship of P. gingivalis with AD development 167 
As mentioned, P. gingivalis is considered a keystone pathogen in periodontitis [12] and it is 168 
adept at manipulating the sub-gingival microbiome and the host’s immune system [44-49]. P. 169 
gingivalis is an intracellular pathogen that has been used to develop AD via periodontal 170 
infection in mice [13, 14]. The infection periodontal model of Ilievski et al. [14] produced the 171 
AD defining hallmark lesions in the mouse brains (Aβ and phosphotau neurofibrillary 172 
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tangles), a finding reproduced in mice by Dominy et al. [50]. Since the Ilievski and the 173 
Dominy models were of wild type mice, there is a high probability that Aβ was cleaved from 174 
its precursor protein into various oligomer sizes following oxidative stress initiated by P. 175 
gingivalis, which in turn activated cathepsin B within the endo/lysosomes [22, 51]. This 176 
intracellular processing of Aβ agrees with the earlier report of Wu et al. [15] showing, that 177 
metabolic processing of the amyloid precursor protein after P. gingivalis lipopolysaccharide 178 
(LPS) was administered into cathepsin B sufficient mice. Other studies in which either P. 179 
gingivalis or its LPS was introduced, supported the development of the AD-like clinical 180 
phenotype [15-17, 52] resulting in impaired spatial learning and memory. All of these 181 
investigations support a causal relationship of periodontitis with the development of AD. 182 
 183 
Mechanisms of cognitive deficit by P. gingivalis infection 184 
Soluble oligomeric Aβ and BBB defects 185 
In line with Dominy et al. [50] confirming P. gingivalis genetic footprints (DNA) in the AD 186 
brains, in vivo infection models of periodontitis are recapitulating hallmark proteins and the 187 
emerging phenotype is supporting cognitive deficit [14-17, 52]. P. gingivalis produces two 188 
types of cysteine proteases (gingipains). They are the lysine specific Kgp and the arginine 189 
specific RgpA and RgpB gingipains [53]. A novel finding described by Dominy et al. [50] is 190 
the capacity of these proteases to hydrolyse the biochemical structure of the protein tau, and 191 
this opens up future avenues for research.  192 
Gingipains activity has the potential to erode endothelial tight junction proteins [24] as 193 
supported by the P. gingivalis/host interactome study [54]. Cognitive deterioration due to 194 
BBB defects in the human elderly individuals are also documented [25] and this may yet be 195 
another contributory factor in mice models displaying AD-like clinical phenotype. In addition, 196 
if the soluble form of the olgomeric Aβ can interfere with synapses and contribute to 197 
cognitive deficit, as proposed by Cline et al. [30]. Then P. gingivalis oral infection can also 198 
contribute to this protein following its entry into the brain [14, 50].  199 
 200 
Inflammation and inflammatory mediators in general 201 
Numerous studies have shown that LPS from Gram negative bacteria either administered 202 
directly into the peritoneum or the brain, induce neuroinflammation in the form of glial cell 203 
activation [55] and when measured, the inflammatory response is accompanied by learning 204 
and memory impairment [56, 57] as a result of IL-1β secretion following peripheral challenge 205 
with LPS [58]. This is in agreement with the Wu et al. [15] hypothesis that systemic 206 
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administration of P. gingivalis LPS leads to cognitive deficit following Aβ liberation in an IL-207 
1β receptor dependent pathway on neurons, (also see [21]). IL-1β cytokine is implicated in 208 
synaptic loss [59, 60] and with reduced long-term potentiation, which is a unit of memory 209 
[59], supporting the role of this cytokine in deteriorating cognition.   210 
 211 
P. gingivalis, complement, and immune dysbiosis 212 
Gingipains are virulence factors of great importance to the immune subversion activity of P. 213 
gingivalis [53]. In the context of the complement cascade, these proteases play a major role. 214 
P. gingivalis oral infection of apolipoprotein E-/- mice demonstrated complement activation in 215 
their brains [13]. Activation of complement does take place in AD brains, where Aβ plaques 216 
are the suggested trigger [61]. If, according to the novel hypothesis of Allen [62] that Aβ 217 
senile plaques are miniature foci of bacterial biofilms, and that the antimicrobial protection 218 
theory of Moir et al. [23] supporting the Aβ antimicrobial peptide idea then the downstream 219 
immune activity triggering complement activation in AD brains does fit. Inappropriately 220 
activated complement compromises the function of healthy neurons, because of their 221 
inadequate shielding from protective proteins that rescue them from the non-specific mode of 222 
activity of this powerful innate immune signaling cascade [63]. During complement 223 
activation, release of several small proteins (opsonins) takes place, which then opsonize to 224 
neurons [13]. Depending on the site of opsonin binding to the neuron, (e.g. at the synaptic 225 
cleft), there remains a potential to disrupt the path of neuronal communication and give way 226 
to cognitive dysfunction. In addition, the continuation of this cyclic cascade will generate 227 
more cytokines and contribute to cognitive deficit (see above). 228 
P. gingivalis infection continues to cleave complement components (C1-C5) through 229 
its gingipains activity, and prevents both deposition of C3b on the bacterial surface and 230 
capture of the C4b binding protein [64-68]. By hijacking the complement regulator C4bp on 231 
the bacterial surface, P. gingivalis prevents assembly of the membrane attack complex and 232 
acquires the ability to regulate C3 convertase [66]. Accordingly, the gingipains do not only 233 
destroy complement through proteolytic degradation, but they also inhibit activation of 234 
complement by binding to the complement inhibitor C4bp [66]. This inhibits complement 235 
action and results in a local accumulation of the anaphylatoxin C5a [69]. P. gingivalis also 236 
exerts C5 convertase-like enzymatic activity and exploits complement-Toll like receptor 237 
(TLR) crosstalk to subvert host defenses and thus escape elimination from the host [45]. 238 
Zhang et al. [52] recently demonstrated that the mechanism by which P. gingivalis impaired 239 
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spatial learning and memory is via TLR crosstalk because inhibiting this pathway rescued 240 
memory in their infection mouse model. 241 
As an analogy to TLR signaling, our in house data clearly showed that CD14, an LPS 242 
binding receptor, expressed on healthy IMR32 neurons (also participates in TLR signaling) 243 
was completely or partially removed following exposure to endo/exotoxins from P. gingivalis 244 
ATCC 33277T and W50, respectively (see Figure 1). Such mechanisms lead to defective 245 
immune surveillance because of their influence in remodeling the periodontal microbiota into 246 
a dysbiotic state. P. gingivalis can also reduce the antibacterial and proinflammatory activity 247 
of C5a by deiminating its C-terminal arginine residues [70]. Degradation of complement 248 
proteins probably allows colonization and proliferation of bacteria possessing higher 249 
sensitivity towards complement killing than found in P. gingivalis itself [47]. Thus, P. 250 
gingivalis may support survival of the entire biofilm community by helping bystander bacteria 251 
evade complement mediated killing [46], whilst neurons survive with compromised function. 252 
These activities have consequences for the developing neuropathology. Thus, the 253 
neuropathology and the clinical functional loss together, constitute the AD diagnosis. P. 254 
gingivalis infection under laboratory conditions are supporting both of these possibilities [13-255 
17, 22, 24, 52]. 256 
 257 
Bacterial factors disrupting synapses 258 
Our in-house in vitro studies in which IMR32 (neuroblastoma-derived) neurons challenged 259 
with P. gingivalis virulence factors (containing LPS and gingipains) indicated considerable 260 
alterations in their actin cytoskeletal filaments following their detection with fluorescein-261 
phalloidin dye. The LPS binding to cell surface membranes caused blebbing [11], whilst the 262 
protease caused the cells to withdraw their processes and round up (see Figure 2). In 263 
summary, the structural alteration of the IMR32 neurons, in vitro, could provide the basis for 264 
the failure of communication between neighboring cells. In addition, excess 265 
bacterial/inflammatory mediators possibly trap between micro spaces of opposing (pre-post) 266 
synapses (synaptic clefts) or adversely affect synaptosomes during their neurotransmitter 267 
release contributing to cognitive loss. These areas are open to future investigations in relation 268 
to memory. Infection of microglia with P. gingivalis in mice has promoted cell migration and 269 
an inflammatory response through gingipain-mediated activation of protease-activated 270 
receptor-2 [71]. We need to clarify if and how infectious episodes impair memory at the 271 
synaptosomal level, rather than at the synaptic cleft level. Such information may refine our 272 
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understanding at an earlier stage of deteriorating cognition albeit at the neurotransmitter 273 
release and its uptake levels. 274 
 275 
Dysbiosis of immune defense by alternative means 276 
miRNA has a role in the virulence of P. gingivalis, contributing to modulation of host-cell 277 
immune responses in a manner that promotes bacterial survival, and progressively reduces the 278 
host’s protective function [49]. Some miRNAs are even associated with P. gingivalis itself 279 
[72], while others (miRNA-128, miRNA-146, miRNA-203, and miRNA-584) are host 280 
derived for inflammation. Bacterium-associated miRNAs are likely to influence the innate 281 
immune response against P. gingivalis, whereas LPS from this bacterium may affect the level 282 
of the host’s miRNA–mRNA interactions. These miRNA-dependent effects may supplement 283 
other forms of deception exerted by P. gingivalis thus subverting innate and adaptive immune 284 
responses possibly by altering gene function [54, 69]. 285 
  286 
P. gingivalis and tau protein phosphorylation  287 
 288 
As mentioned earlier, Ilievski et al. [14] demonstrated that P. gingivalis infection can lead to 289 
tau phosphorylation and neurofibrillary tangle formation in mice. The neurons that develop 290 
these hallmark lesions in the human AD brain are cells with compromised function, and the 291 
structural change in the nerve cell soma and axons, the later disrupting their connectivity. The 292 
effect of gingipains on the integrity of actin filaments seen with IMR32 neurons (Figure 2) 293 
may be analogous to the neurofibrillary tangle bearing neurons in AD.  This structural change 294 
is likely to be detrimental to their communications with other brain cells resulting in 295 
deteriorated cognition.    296 
Previously, we have discussed outer membrane vesicles (microbullets) from P. 297 
gingivalis [73] playing a role in AD development. P. gingivalis cultures produce them in vast 298 
numbers, suggesting they constitute the main superhighway of communication with other 299 
bacteria in the biofilm [74]. Since they carry additional arsenals of weapons to manipulate 300 
their entry into disparate organs, disrupt actin structures, erode epithelial junctional proteins, 301 
hijack phagocytosis, destroy tissues, and affect complement related genes, they may also be 302 
responsible for transducing proinflammatory signaling cascades that ultimately lead to disease 303 
defining lesion development and cognitive decline, typical of clinical AD.  304 
Ilievski et al. [14] demonstrated a chronic infection with live P. gingivalis strain W83 305 
for 22 weeks with both the hallmark lesions (Aβ and NFTs) that characterize AD with tau 306 
Commented [SKS<oD1]: I think this is the sentence 
asked to be clarified?, needs addressing 
11 
 
protein phosphorylation at the serine396 (ser396) residue. This generated a new concept that an 307 
oral infective focus in neurological diseases may result in dementia. Up until now, abnormally 308 
phosphorylated tau protein has not featured negatively in the pathophysiology of periodontal 309 
disease per se. However, Adamowicz et al. [75] implicated the role of glycogen synthase kinase 310 
3 (GSK-3) in bacterial-induced periodontitis because its inhibition rescued bone loss. Thus, 311 
GSK-3 may be influencing phosphorylation of brain tau via immune responses mediated by P. 312 
gingivalis, in the Ilievski et al. [14] study. GSK-3β appears to mediate proinflammatory 313 
cytokine production during bacterial infections because inhibition of GSK-3β leads to an innate 314 
hypo-reactivity to oral pathogens [76]. Macrophages treated with LPS, in vitro suggest that 315 
GSK-3β stimulates interferon-β (IFN-β) production via c-Jun thus activating a transcription 316 
factor (ATF)-2-dependent mechanism [76]. GSK-3β also negatively regulates production of the 317 
endogenous IL-1β antagonist, IL-1R, via its ability to regulate the MAPK and ERK 1/2 in LPS-318 
stimulated innate immune cells. There is no doubt that further research will widen investigation 319 
of these pathways for more direct causal links with oral disease and dementing diseases with 320 
cognitive deterioration. 321 
The Dominy et al. [50] publication has provided a stronger argument for the role of 322 
pathogenic tau in AD development. In their in vitro neuronal culture system, Dominy et al. 323 
[50] demonstrate that tau is a substrate for gingipains and show a low molecular weight band 324 
corresponding to a novel tau peptide. Further research will establish if it is neurotoxic or not.   325 
  326 
P. gingivalis and lymphocytes 327 
It is possible that T cell entry into the AD brain is restricted and this somehow influences 328 
ineffective clearance of the Aβ by macrophages and the resident microglia. Baek et al. [77] 329 
found that Treg cells (subpopulation of T cells) had an effect on cognitive function by 330 
decreasing Aβ deposition and inflammatory cytokine secretion in a 3xTg-AD mice model. In 331 
contrast, depletion of Tregs increased the onset of cognitive deficit, accelerated the amount of 332 
the Aβ burden, enhanced microglia/macrophage responses and decreased glucose metabolism 333 
in 3xTg-AD mice. In patients with atherosclerosis, the Treg population was reduced if they  334 
harbored type II fimA of P. gingivalis compared to those with other types of fimbriae [78]. 335 
Therefore, P. gingivalis type II fimA could be associated with dysregulation of Tregs in 336 
extraoral lesions. Severe immunosuppression seems to favor not only colonization with 337 
varying serotypes of periodontopathogenic bacteria, but also with species not commonly 338 
found in the subgingival microbiota [79]. In the brain, this may contribute to the 339 
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establishment of a multi species microbiota, previously reported in AD patients [80]. In 340 
addition, accumulation of insoluble and toxic Aβ42 has detrimental effect on the neighboring 341 
neurons and their connections, which may have further implications for neurodegeneration 342 
and related cognitive loss. 343 
 344 
Conclusions 345 
Dominy et al. [50] have recently provided robust data linking the main pathogen (P. 346 
gingivalis) of periodontitis with the cause of AD. This bacterium appears to migrate from the 347 
mouth to the brain of some individuals as they age and a significant proportion of subjects 348 
who go onto developing AD. This further highlights the possibility that AD has a microbial 349 
infection origin. Ilievski et al. [14] provide evidence for P. gingivalis infection having causal 350 
associations by reproducing the hallmark lesions. Four independent studies carried out in mice 351 
infected with P. gingivalis provide causal links through impaired learning and memory. The 352 
suggested mechanism is related to the TLR crosstalk and this may have relevance to the 353 
inflammasome formation with the resulting cytokines (mature IL-1β) being linked to memory 354 
disturbances.  355 
These studies reinforce the advice that oral hygiene is important in keeping pathogens 356 
low and encouraging greater diversity of commensals (health promoting bacteria). This 357 
provides a healthy microbiome and better general health. Health authorities need to heed this 358 
warning and take research based evidence seriously. The UK NHS England provides a 359 
recommendable oral health toolkit for the elderly to maintain better oral hygiene with the aim 360 
of delaying/preventing AD.  361 
 362 
Conflict of Interest The authors declare no conflict of interest. 363 
 364 
Human and Animal Rights and Informed Consent    365 
Not applicable. This is a review of literature and does not rely on freshly obtained data from 366 
human and/or animal studies. Figures are from our in-house cell culture studies that are 367 
exempt from ethical issues.  368 
 369 
References 370 
 371 
Papers of particular interest, published recently, have been highlighted as:  372 
13 
 
*Of importance 373 
**Of major importance. 374 
***Of significant importance 375 
 376 
1. Olsen I. From the Acta Prize Lecture 2014: the periodontal-systemic connection seen 377 
from a microbiological standpoint. Acta Odontol Scand. 2015; 73(8): 563-8. DOI: 378 
10.3109/00016357.2015.1007480. 379 
2. Olsen I, Singhrao SK. Can oral infection be a risk factor for Alzheimer's disease? J 380 
Oral Microbiol. 2015; 7: 29143. DOI: 10.3402/jom.v7.29143. 381 
3. Olsen I, Singhrao SK, Potempa J. Citrullination as a plausible link to periodontitis, 382 
rheumatoid arthritis, atherosclerosis and Alzheimer’s disease. J. Oral Microbiol. 383 
2018; 10(1):1487742. DOI: 10.1080/20002297.2018.1487742. 384 
4. **Chen CK, Wu YT, Chang YC. Periodontal inflammatory disease is associated with 385 
the risk of Parkinson's disease: a population-based retrospective matched-cohort 386 
study. PeerJ. 2017; 5:e3647. DOI: 10.7717/peerj.3647. Reducing periodontitis may 387 
modify the risk of developing Parkinson’s disease. 388 
5. **Chen CK, Huang JY, Wu YT, Chang YC. Dental scaling decreases the risk of 389 
Parkinson's disease: A nationwide population-based nested case-control study. Int J 390 
Environ Res Public Health. 2018; 15(8). pii: E1587. DOI: 10.3390/ijerph15081587. 391 
First study to show that patients without periodontitis who received dental 392 
scaling over 5 consecutive years had a significantly lower risk of developing 393 
Parkinson’s disease. 394 
6. **Pang S, Li J, Zhang Y, Chen J. Meta-analysis of the relationship between the 395 
APOE gene and the onset of Parkinson's disease dementia. Parkinsons Dis. 2018; 396 
2018: 9497147. DOI: 10.1155/2018/9497147. APOE genotypes, ɛ3/4 and ɛ4/4 may 397 
be risk factors for Parkinson’s disease dementia. 398 
7. **Soscia SJ, Kirby JE, Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, et al. 399 
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. 400 
PLoS One. 2010; 5(3): e9505. DOI: 10.1371/journal.pone.0009505. Abeta is a 401 
hitherto unrecognized antimicrobial peptide that may normally act in the innate 402 
immune system. 403 
8. Kumar DK, Choi SH, Washicosky KJ, Eimer WA, Tucker S, Ghofrani J, et al. 404 
Amyloid-β peptide protects against microbial infection in mouse and worm models of 405 
Formatted: Hidden
Formatted: Hidden
14 
 
Alzheimer's disease. Sci Transl Med. 2016; 8(340): 340ra72. DOI: 406 
10.1126/scitranslmed.aaf1059. 407 
9. **Park SC, Moon JC, Shin SY, Son H, Jung YJ, Kim NH, et al. Functional 408 
characterization of alpha-synuclein protein with antimicrobial activity. Biochem     409 
Biophys Res Commun. 2016; 478(2): 924-8. DOI: 10.1016/j.bbrc.2016.08.052. 410 
Alpha-synuclein appears to be a natural antimicrobial peptide in addition to 411 
having a role in neutransmitter release. 412 
10. Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell 413 
T, Washicosky KJ, et al. Alzheimer's disease-associated β-Amyloid is rapidly seeded 414 
by Herpesviridae to protect against brain infection. Neuron. 2018; 99(1): 56-63.e3. 415 
DOI: 10.1016/j.neuron.2018.06.030.  416 
11. **Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean S. Determining the presence 417 
of periodontopathic virulence factors in short-term postmortem Alzheimer's disease 418 
brain tissue. J Alzheimers Dis. 2013; 36(4): 665-77. DOI: 10.3233/JAD-121918. The 419 
original study confirmed that P. gingivalis lipopolysaccharide reaches the 420 
Alzheimer disease brain. 421 
12. *Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat 422 
Rev Microbiol. 2012; 10(10): 717-25. DOI: 10.1038/nrmicro2873. The keystone-423 
pathogen hypothesis holds that certain low-abundance microbial pathogens can 424 
orchestrate inflammatory disease by remodelling a normally benign microbiota 425 
into a dysbiotic one. 426 
13. ***Poole S, Singhrao SK, Chukkapalli S, Rivera M, Velsko I, Kesavalu L, et al. 427 
Active invasion of Porphyromonas gingivalis and infection-induced complement 428 
activation in ApoE-/- mice brains. J Alzheimers Dis. 2015; 43(1): 67-80. DOI: 429 
10.3233/JAD-140315. P. gingivalis was able to access the ApoE-/- mice brain 430 
contributing to complement activation by bystander neuronal injury. 431 
14. ***Ilievski V, Zuchowska PK, Green SJ, Toth PT, Ragozzino ME, Le K, et al. 432 
Chronic oral application of a periodontal pathogen results in brain inflammation, 433 
neurodegeneration and amyloid beta production in wild type mice. PLoS One. 2018; 434 
13(10): e0204941. DOI: 10.1371/journal.pone.0204941. First study to show 435 
neurodegeneration and formation of extracellular Aß42 and phosphotau bound 436 
to neurofibrillary tangles in young adult wild type mice after repeated 437 
application of P. gingivalis. 438 
15 
 
15. ***Wu Z, Ni J, Liu Y, Teeling JL, Takayama F, Collcutt A, et al. Cathepsin B plays a 439 
critical role in inducing Alzheimer's disease-like phenotypes following chronic 440 
systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. 441 
Brain Behav Immun. 2017; 65: 350-61. DOI: 10.1016/j.bbi.2017.06.002. Chronic 442 
systemic exposure to PgLPS induced AD-like phenotypes, including microglia-443 
mediated neuroinflammation, intracellular Aβ accumulation in neurons and 444 
impairment of the learning and memory functions in the middle-aged mice in a 445 
CatB-dependent manner. Linked IL-1β involvement in memory deterioration.  446 
16. **Ishida N, Ishihara Y, Ishida K, Tada H, Funaki-Kato Y, Hagiwara M, et al. 447 
Periodontitis induced by bacterial infection exacerbates features of Alzheimer's 448 
disease in transgenic mice. NPJ Aging Mech Dis. 2017; 3: 15. DOI: 10.1038/s41514-449 
017-0015-x. Periodontitis caused by P. gingivalis may exacerbate brain Aβ 450 
deposition, leading to increased cognitive impairments, by a mechanism that 451 
involves triggering brain inflammation. 452 
17. **Ding Y, Ren J, Yu H, Yu W, Zhou Y. Porphyromonas gingivalis, a periodontitis 453 
causing bacterium, induces memory impairment and age-dependent 454 
neuroinflammation in mice. Immun Ageing. 2018; 15: 6. DOI: 10.1186/s12979-017-455 
0110-7. The learning and memory abilities of the middle-aged mice infected with 456 
P. gingivalis were impaired. 457 
18. Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. 458 
Alzheimer's disease. Nat Rev Dis Primers. 2015; 1: 15056. DOI: 459 
10.1038/nrdp.2015.56. 460 
19. **Singhrao SK, Harding A, Chukkapalli S, Olsen I, Kesavalu L, Crean S. 461 
Apolipoprotein E related co-morbidities and Alzheimer's disease. J Alzheimers Dis. 462 
2016; 51(4): 935-48. DOI: 10.3233/JAD150690. The apolipoprotein E gene allele 4 463 
is the plausible commonality for the etiology of co-morbidities that eventually 464 
result from periodontal diseases and ultimately progress to mixed pathologies 465 
and dementia. 466 
20. Li J, Luo J, Liu L, Fu H, Tang L. The genetic association between apolipoprotein E 467 
gene polymorphism and Parkinson disease: A meta-analysis of 47 studies. Medicine 468 
(Baltimore). 2018; 97(43): e12884. DOI: 10.1097/MD.0000000000012884. 469 
21. *Singhrao SK, Olsen I. Assessing the role of Porphyromonas gingivalis in 470 
periodontitis to determine a causative relationship with Alzheimer’s disease. J Oral 471 
Microbiol. 2019; 1563405. DOI: 10.1080/20002297.2018.1563405. Summation of 472 
16 
 
animal studies supporting the P. gingivalis infection link with AD risk factor 473 
development. 474 
22. *Rokad F, Moseley R, Hardy RS, Chukkapalli S, Crean S, Kesavalu L, et al. Cerebral 475 
oxidative stress and microvasculature defects in TNF-α expressing transgenic and 476 
Porphyromonas gingivalis-infected ApoE-/- mice. J Alzheimers Dis. 2017; 60(2): 359-477 
69. DOI: 10.3233/JAD-170304. The hippocampal microvascular structure of P. 478 
gingivalis-infected ApoE-/- mice possesses elevated oxidative stress levels, 479 
resulting in the associated tight junction proteins being susceptible to increased 480 
oxidative/proteolytic degradation, leading to hydrolysis of the amyloid precursor 481 
protein to generate Aβ in wild type mice infected with P. gingivalis. 482 
23. ***Moir RD, Lathe R, Tanzi RE. The antimicrobial protection hypothesis of 483 
Alzheimer's disease. Alzheimers Dement. 2018; 14(12): 1602-14. DOI: 484 
10.1016/j.jalz.2018.06.3040. The new Antimicrobial Protection Hypothesis reveals 485 
brain microbial burden may directly generate β-amyloid deposits, inflammation, 486 
and AD progression. This study underpins the role of microbes in the 487 
pathogenesis of AD. 488 
24. ***Singhrao SK, Chukkapalli S, Poole S, Velsko I, Crean SJ, Kesavalu L. Chronic 489 
Porphyromonas gingivalis infection accelerates the occurrence of age-related granules 490 
in ApoE-/- mice brains. J Oral Microbiol. 2017; 9(1):1270602. DOI: 491 
10.1080/20002297.2016.1270602. ApoE-/- mice showing the earliest inflammation-492 
mediated tissue injury, accompanied by cerebral blood-brain barrier 493 
breachment. 494 
25. **Bowman GL, Dayon L, Kirkland R, Wojcik J, Peyratout G, Severin IC, et al. 495 
Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older 496 
adults. Alzheimers Dement. 2018; 14(12):1640-50. DOI: 10.1016/j.jalz.2018.06.2857. 497 
Blood-brain-barrier breakdown is associated with cognitive decline and 498 
inflammation in non-demented elders. 499 
26. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and 500 
problems on the road to therapeutics. Science. 2002; 297(5580): 353-6. Erratum in: 501 
Science 2002; 297(5590): 2209. 502 
27. **Boche D, Donald J, Love S, Harris S, Neal JW, Holmes C, et al. Reduction of 503 
aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 504 
17 
 
immunisation in Alzheimer's disease. Acta Neuropathol. 2010; 120(1): 13-20. 505 
Removal of Abeta from the brain via immunisation  does not improve memory. 506 
28. *Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical 507 
basis of cognitive alterations in Alzheimer's disease: synapse loss is the major 508 
correlate of cognitive impairment. Ann Neurol. 1991; 30(4): 572-80. Origins of the 509 
synaptic loss theory to explain cognitive deficit. 510 
29. *Masliah E, Hansen L, Albright T, Mallory M, Terry RD. Immunoelectron 511 
microscopic study of synaptic pathology in Alzheimer's disease. Acta Neuropathol. 512 
1991; 81(4): 428-33. Provides evidence to support the synaptic loss theory.  513 
30. **Cline EN, Bicca MA, Viola KL, Klein WL. The Amyloid-β Oligomer Hypothesis: 514 
Beginning of the third decade. J Alzheimers Dis. 2018; 64(s1): S567-S610. DOI: 515 
10.3233/JAD-179941. Revised Amyloid-β oligomer theory.  Soluble Aβ oligomers 516 
accumulate in an AD-dependent manner in human and animal model brain 517 
tissue and, experimentally, to impair learning and memory and instigate major 518 
facets of AD neuropathology, including tau pathology, synapse deterioration and 519 
loss, inflammation, and oxidative damage. 520 
31. **Olsen I, Singhrao SK. Inflammasome involvement in Alzheimer’s disease. J 521 
Alzheimers Dis. 2016; 5;54(1): 45-53. This review supports the mechanism of P. 522 
gingivalis infection promoting cognitive deficit (see ref 52).  523 
32. Gatz M, Mortimer JA, Fratiglioni L, Johansson B, Berg S, Reynolds CA, et al. 524 
Potentially modifiable risk factors for dementia in identical twins. Alzheimers 525 
Dement. 2006; 2: 110-7. 526 
33. Stein PS, Desrosiers M, Donegan SJ, Yepes JF, Kryscio RJ. Tooth loss, dementia and 527 
neuropathology in the Nun study. J Am Dent Assoc. 2007; 138(10): 1314-22; quiz 528 
1381-2. 529 
34. Stein PS, Kryscio RJ, Desrosiers M, Donegan SJ, Gibbs MB. Tooth loss, 530 
apolipoprotein E, and decline in delayed word recall. J Dent Res. 2010; 89(5): 473-7. 531 
DOI: 10.1177/0022034509357881. 532 
35. Kamer AR, Craig RG, Pirraglia E, Dasanayake AP, Norman RG, Boylan RJ, et al. 533 
TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer's 534 
disease patients and normal subjects. J Neuroimmunol. 2009; 216(1-2): 92-7. DOI: 535 
10.1016/j.jneuroim.2009.08.013. 536 
18 
 
36. *Farhad SZ, Amini S, Khalilian A, Barekatain M, Mafi M, Barekatain M, et al. The 537 
effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in 538 
Alzheimer disease. Dent Res J (Isfahan). 2014; 11(5): 549-52. Not all of the AD 539 
cases they examined at the clinical level co-existed with periodontitis. 540 
37. **Sparks Stein P, Steffen MJ, Smith C, Jicha G, Ebersole JL, Abner E, et al. Serum 541 
antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. 542 
Alzheimers Dement. 2012; 8(3): 196-203. DOI: 10.1016/j.jalz.2011.04.006. A 543 
laboratory study that agreed with the epidemiological study of Chen et al., (ref 544 
38) for the 10 year timeline in risk development following periodontitis diagnosis 545 
38. **Chen CK, Wu YT, Chang YC. Association between chronic periodontitis and the 546 
risk of Alzheimer's disease: a retrospective, population-based, matched-cohort study. 547 
Alzheimers Res Ther. 2017; 9(1): 56. DOI: 10.1186/s13195-017-0282-6. A 10-year 548 
CP exposure was associated with a 1.707-fold increase in the risk of developing 549 
AD. 550 
39. Stewart R, Weyant RJ, Garcia ME, Harris T, Launer LJ, Satterfield S, et al. Adverse 551 
oral health and cognitive decline: the health, aging and body composition study. J Am 552 
Geriatr Soc. 2013; 61(2): 177-84. DOI: 10.1111/jgs.12094.  553 
40. Kaye EK, Valencia A, Baba N, Spiro A, 3rd, Dietrich T, Garcia RI. Tooth loss and 554 
periodontal disease predict poor cognitive function in older men.  DOI: 555 
10.1111/j.1532-5415.2010.02788.x. 556 
41. *Daly B, Thompsell A, Sharpling J, Rooney YM, Hillman L, Wanyonyi KL, et al. 557 
Evidence summary: the relationship between oral health and dementia. Br Dent J. 558 
2018;223(11): 846-53. DOI: 10.1038/sj.bdj.2017.992. Poor oral hygiene is 559 
associated with dementia, and more so amongst people in advanced stages of the 560 
disease. 561 
42. *de Souza Rolim T, Fabri GM, Nitrini R, Anghinah R, Teixeira MJ, de Siqueira JT, et 562 
al. Oral infections and orofacial pain in Alzheimer's disease: a case-control study. J 563 
Alzheimers Dis. 2014; 38(4): 823-9. DOI: 10.3233/JAD-131283. An interventional 564 
study on the periodontal treatment in AD patients indicated a plausible causal 565 
relationship in demented individuals. 566 
43. *Emanuel R, Sorensen A. A study of oral health prevention behaviours for patients 567 
with early stage dementia. Br Dent J. 2018; 224(1): 38-42. DOI: 568 
10.1038/sj.bdj.2018.5. There was clearly scope for improving oral health 569 
education and prevention for dementia patients. 570 
19 
 
44. *Hajishengallis G. Immune evasion strategies of Porphyromonas gingivalis. J Oral 571 
Biosci. 2011; 53(3): 233-40. Exploitation of Toll-like receptor-2, complement 572 
receptor 3, C5a anaphylatoxin receptor, and CXC-chemokine receptor 4 by P. 573 
gingivalis allows the pathogen to escape elimination, obtain nutrients, and 574 
collaterally inflict periodontal tissue injury. 575 
45. *Hajishengallis G, Lambris JD. Complement and dysbiosis in periodontal disease. 576 
Immunobiology. 2012; 217(11): 1111-6. DOI: 10.1016/j.imbio.2012.07.007. P. 577 
gingivalis expresses C5 convertase-like enzymatic activity and adeptly exploits 578 
complement-TLR crosstalk to subvert host defenses and escape elimination. 579 
46. Hajishengallis G, Abe T, Maekawa T, Hajishengallis E, Lambris JD. Role of 580 
complement in host-microbe homeostasis of the periodontium. Semin Immunol. 2013; 581 
25(1): 65-72. DOI: 10.1016/j.smim.2013.04.004. 582 
47. Hussain M, Stover CM, Dupont A.  P. gingivalis in periodontal disease and 583 
atherosclerosis - scenes of action for antimicrobial peptides and complement. Front 584 
Immunol. 2015; 6: 45. DOI: 10.3389/fimmu.2015.00045. 585 
48. Olsen I, Hajishengallis G. Major neutrophil functions subverted by Porphyromonas 586 
gingivalis. J Oral Microbiol. 2016; 8: 30936. DOI: 10.3402/jom.v8.30936. 587 
49. Olsen I, Singhrao SK, Osmundsen H. Periodontitis, pathogenesis and progression: 588 
miRNA-mediated cellular responses to Porphyromonas gingivalis. J Oral Microbiol. 589 
2017; 9(1): 1333396. DOI: 10.1080/20002297.2017.1333396. 590 
50. ***Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. 591 
Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease 592 
causation and treatment with small-molecule inhibitors. Sci. Adv. 2019; 5: eaau3333. 593 
This study has provided the strongest evidence for causal links of P. gingivalis 594 
infection with AD. It has raised the vital awareness in periodontitis and AD 595 
developmental links. It offers hope for a future treatment via their gingipain 596 
inhibiting drugs 597 
51. **Llorente P, Kristen H, Sastre I, Toledano-Zaragoza A, Aldudo J, Recuero M, et al. A 598 
free radical-generating system regulates amyloid oligomers: Involvement of cathepsin 599 
B.  J Alzheimer’s Dis. 2018; 66: 1397–408. DOI 10.3233/JAD-170159. Cathepsin B 600 
participates in the changes of amyloid oligomer induced by mild oxidative stress. 601 
This supports the oxidative stress related damage following P. gingivalis infection 602 
as reported in reference 22.  603 
20 
 
52. **Zhang J, Yu C, Zhang X, Chen H, Dong J, Lu W, et al. Porphyromonas gingivalis 604 
lipopolysaccharide induces cognitive dysfunction, mediated by neuronal inflammation 605 
via activation of the TLR4 signaling pathway in C57BL/6 mice. J Neuroinflammation. 606 
2018; 15(1): 37. DOI: 10.1186/s12974-017-1052-x. Offer a mechanism of how P. 607 
gingivalis-LPS-induced neuroinflammation plays an important role in cognitive 608 
impairment. This reference complements the review by Olsen and Singhrao 609 
reference no 31.  610 
53. Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J 611 
Periodontol. 2003; 74(1): 111-8.  612 
54. *Carter CJ, France J, Crean S, et al. The Porphyromonas gingivalis/host interactome 613 
shows enrichment in GWASdb genes related to Alzheimer’s disease, diabetes and 614 
cardiovascular diseases. Front Aging Neurosci. 2017; 9: 408. DOI: 615 
10.3389/fnagi.2017.00408 P. gingivalis intractome supporting AD susceptibility 616 
genes or gene expression changes. In particular lists the supporting references for 617 
eroding proteins that keep epithelial/endothelial barriers intact. 618 
55. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic 619 
endotoxin challenges exacerbate the local inflammatory response and increase neuronal 620 
death during chronic neurodegeneration. J Neurosci. 2005; 25: 9275-84. 621 
56. Tanaka S, Ide M, Shibutani T, Ohtaki H, Numazawa S, Shioda S, et al. 622 
Lipopolysaccharide-induced microglial activation induces learning and memory deficits 623 
without neuronal cell death in rats. J Neurosci Res. 2006; 83: 557–66. 624 
57. Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW. 625 
Neuroinflammation and disruption in working memory in aged mice after acute 626 
stimulation of the peripheral innate immune system. Brain Behav Immun. 2008; 18: 627 
223-30. 628 
58. *Henry CJ, Huang Y, Wynne AM, Godbout JP. Peripheral lipopolysaccharide (LPS) 629 
challenge promotes microglial hyperactivity in aged mice that is associated with 630 
exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 631 
cytokines. Brain Behav Immun. 2009; 23(3): 309-17. Implicates LPS with release of IL-632 
1β and intracerebral inflammation 633 
59. *Bellinger FP, Madamba S, Siggins, GR. Interleukin 1 beta inhibits synaptic strength 634 
and long-term potentiation in the rat CA1 hippocampus. Brain Res. 1993; 628: 227-34. 635 
Implicate IL-1β in cognitive deficit. 636 
21 
 
60. Mishra A, Kim HJ, Shin AH, Thayer SA. Synapse loss induced by interleukin-1beta 637 
requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol. 2012; 7(3): 638 
571-8. DOI: 10.1007/s11481-012-9342-7. 639 
61. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and 640 
Alzheimer's disease. Neurobiol Aging. 2000; 21(3): 383-421. 641 
62. Allen HB. Alzheimer's disease: Assessing the role of spirochetes, biofilms, the immune 642 
system, and amyloid-β with regard to potential treatment and prevention. J Alzheimers 643 
Dis. 2016; 53(4):1271-6. DOI: 10.3233/JAD-160388. 644 
63. Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P. Spontaneous classical 645 
pathway activation and deficiency of membrane regulators render human neurons 646 
susceptible to complement lysis. Am J Pathol. 2000; 157(3): 905-18. 647 
64. Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J, Hugli TE. Activation of 648 
complement components C3 and C5 by a cysteine proteinase (gingipain-1) from 649 
Porphyromonas (Bacteroides) gingivalis. J Biol Chem. 1992; 267(26): 18902-7. 650 
65. Popadiak K, Potempa J, Riesbeck K, Blom AM. Biphasic effect of gingipains from 651 
Porphyromonas gingivalis on the human complement system. J Immunol. 2007; 652 
178(11): 7242-50. 653 
66. Potempa M, Potempa J, Okroj M, Popadiak K, Eick S, Nguyen KA, et al. Binding of 654 
complement inhibitor C4b-binding protein contributes to serum resistance of 655 
Porphyromonas gingivalis. J Immunol. 2008; 181(8): 5537-44. 656 
67. Slaney JM, Curtis MA. Mechanisms of evasion of complement by Porphyromonas 657 
gingivalis. Front Biosci. 2008; 13: 188-96. 658 
68. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, Magotti P, et al. Microbial 659 
hijacking of complement-toll-like receptor crosstalk. Sci Signal. 2010; 3(109): ra11. 660 
DOI: 10.1126/scisignal.2000697. 661 
69. *Olsen I, Singhrao SK. Genetic defects, complement and Porphyromonas gingivalis 662 
immune subversion in Alzheimer’s disease. J Oral Microbiol. 2018; submitted. P. 663 
gingivalis is a keystone pathogen for periodontitis and its co-morbidities because 664 
of the mastery of this bacterium at subverting selective steps in the immune 665 
system for effective dysbiosis, which in turn amplifies altered gene functions in 666 
Alzheimer’s disease. 667 
70. *Bielecka E, Scavenius C, Kantyka T, Jusko M, Mizgalska D, Szmigielski B, et al. 668 
Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin 669 
C5a activity. J Biol Chem. 2014; 289(47): 32481-7. DOI: 10.1074/jbc.C114.617142. In 670 
22 
 
the context of previous studies, which showed crosstalk between C5aR and Toll-671 
like receptors, and enhanced arthritis development in mice infected with PPAD-672 
expressing P. gingivalis, a crucial role of PPAD in the virulence of P. gingivalis 673 
was supported. 674 
71. *Liu Y, Wu Z, Nakanishi Y, Ni J, Hayashi Y, Takayama F, et al. Infection of microglia 675 
with Porphyromonas gingivalis promotes cell migration and an inflammatory response 676 
through the gingipain-mediated activation of protease-activated receptor-2 in mice. Sci 677 
Rep. 2017; 7(1): 11759. DOI: 10.1038/s41598-017-12173-1. The authors provide the 678 
first evidence that Rgp and Kgp cooperatively contribute to the P. gingivalis-679 
induced cell migration and expression of proinflammatory mediators through the 680 
activation of protease-activated receptor 2. 681 
72. Choi JW, Kim SC, Hong SH, Lee HJ. Secretable small RNAs via outer membrane 682 
vesicles in periodontal pathogens. J Dent Res. 2017; 96: 458–66. DOI: 683 
10.1177/0022034516685071. 684 
73. *Singhrao SK, Olsen I. Are Porphyromonas gingivalis outer membrane vesicles, 685 
microbullets for sporadic Alzheimer’s disease manifestation?  J Alzheimers Dis Rep. 686 
2018; 1: 1-10. DOI: 10.3233/ADR-180080. Bacterial cultures and established oral 687 
biofilms generate vast numbers of microvesicles and P. gingivalis outer membrane 688 
vesicles encase key virulence factors (LPS, gingipains, capsule, fimbriae) as 689 
though they are complete destructive "microbullets" when shed in the host. 690 
74. Schertzer JW, Whiteley M. Microbial communication superhighways. Cell. 2011; 691 
144(4): 469-70. DOI: 10.1016/j.cell.2011.02.001.  692 
75. **Adamowicz K, Wang H, Jotwani R, Zeller I, Potempa J, Scott DA. Inhibition of 693 
GSK3 abolishes bacterial-induced periodontal bone loss in mice. Mol Med. 2012; 18: 694 
1190-6. DOI: 10.2119/molmed.2012.00180. This study confirms the relevance of 695 
prior in vitro phenomena and establish GSK3 as a novel, efficacious therapeutic 696 
preventing periodontal disease progression in a susceptible host. 697 
76. Wang H, Brown J, Martin M. Glycogen synthase kinase 3: a point of convergence for 698 
the host inflammatory response. Cytokine. 2011;53: 130–40. 699 
77. Baek H, Ye M, Kang GH, Lee C, Lee G, Choi DB, et al. Neuroprotective effects of 700 
CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model. 701 
Oncotarget. 2016; 7(43): 69347-57. DOI: 10.18632/oncotarget.12469. 702 
23 
 
78. Yang J, Wu J, Liu Y, Huang J, Lu Z, Xie L, et al. Porphyromonas gingivalis infection 703 
reduces regulatory T cells in infected atherosclerosis patients. PLoS One. 2014; 9(1): 704 
e86599. DOI: 10.1371/journal.pone.0086599. 705 
79. Gonçalves LS, Ferreira SM, Silva A Jr, Villoria GE, Costinha LH, Souto R, et al. 706 
Association of T CD4 lymphocyte levels and subgingival microbiota of chronic 707 
periodontitis in HIV-infected Brazilians under HAART. Oral Surg Oral Med Oral 708 
Pathol Oral Radiol Endod. 2004; 97(2): 196-203. 709 
80. Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, et 710 
al. 16S rRNA Next Generation Sequencing analysis shows bacteria in Alzheimer's 711 
post-mortem brain. Front Aging Neurosci. 2017; 9: 195. DOI: 712 
10.3389/fnagi.2017.0019. 713 
 714 
 715 
Figure legends 716 
Figure 1. Western blot showing CD14 protein on the human neuroblastoma cell line 717 
IMR32. a) is an immunoblot of cell lysate prepared from IMR32 neurons following 718 
their standard growth culture medium and incubation conditions, no exposure to 719 
virulence factors (control) (lane 1). and cIMR32 neurons cultured in their growth 720 
medium to which ontrol with P. gingivalis sterile growth medium diluted 1:4 from 721 
stockfor P. gingivalis  was addedcultures (lane 2)., IMR32 neurons in their growth 722 
medium plus P. gingivalis ATCC 33277T conditioned medium diluted 1:4 from stock 723 
(lane 3) with exposure (test) to P. gingivalis ATCC 33277T (lane 3) and strain W50 724 
conditioned medium (diluted 1:4 from stock) (lane 4) spent medium (diluted 1:4 from 725 
stock) for 24 h. The proteins were separated by SDS-PAGE electrophoresis and 726 
electro transferred onto the PVDF (polyvinylidene difluoride) membrane. Following 727 
incubation of the membrane overnight with mouse anti-CD14 antibody, clear bands 728 
around the 55 kDa molecular weight were seen (in the control lanes 1 and 2, long 729 
arrow) indicatesing that the CD14 receptor protein was expressed present on control 730 
by these cells. Upon challenge with P. gingivalis 33277T the band completely 731 
diminished (lane 3, CD14 cleaved from cell membrane). Treatment of the same cells 732 
with the W50 strain surprisingly, only partially cleaved CD14 (lane 4) as compared 733 
with the control lanes 1 and 2. b) IMR32 cells grown on coverslips were also 734 
incubated with the same anti-CD14 antibody. The green colour shows CD14 labelling 735 
on the surface membrane of cells confirmingmeaning that the receptor is intact. The 736 
24 
 
red colour indicates the nucleus due to propidium iodide uptake from the mounting 737 
medium. c) Following exposure to P. gingivalis 33277T, the cells for 24 h (as for the 738 
blot), the green labelling was missing and correlated with the blot data. d) Exposure to 739 
P. gingivalis W50, demonstrated green labelling on the membranes again correlating 740 
with the blot data. 741 
 742 
 743 
 744 
 745 
Figure 2 746 
IMR32 neurons in culture: Fluorescein-phalloidin (5 units/ml final, for 30 min) 747 
labelling for actin cytoskeletal protein (green), (nuclei = red due to propidium 748 
iodide uptake).  a) IMR32 monolayer in growth medium shows long processes of 749 
the cells extending outwards. b) Exposure to P. gingivalis ATCC 33277T, spent 750 
medium (diluted 1:4) for 6 h demonstrated the processes thickened, whilst the cell 751 
soma enlarged. c) As for b, but after 24 h exposure, the cells rounded up and 752 
detached. Images taken after examining the cells under the 510 series Zeiss 753 
25 
 
confocal microscope (Carl Zeiss Ltd). Micron bar = 10754 
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